Literature DB >> 3036036

Inhibition of protein phosphorylation by chloroquine.

H Kalisz, G Pohlig, H Holzer.   

Abstract

The rapid phase of fructose-1,6-bisphosphatase (FBPase) inactivation following glucose addition to starved yeast cells [reported previously] is inhibited on addition of 10 mM chloroquine (CQ) at about pH 8. This inhibition of inactivation was shown to be due to the prevention of phosphorylation of the enzyme. CQ was also found to inhibit general protein phosphorylation in the yeast cells. Glycolysis, as observed by changes in intracellular glucose-6-phosphate and extracellular glucose and ethanol concentrations, was shown to be significantly inhibited in cells treated with CQ. Similarly, a decrease in ATP concentrations was observed. However, during the early stages of phosphorylation of FBPase, levels of ATP were similar in cells containing CQ as in those without CQ. Thus, decrease in ATP levels is not thought to be significantly responsible for the inhibition of protein phosphorylation. However, the phosphorylating activity of cyclic AMP-dependent protein kinases is inhibited in vitro by relatively low concentrations of CQ. Thus, prevention of protein phosphorylation by CQ is believed to be due to inhibition of protein kinases in yeast cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036036     DOI: 10.1007/BF00463481

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  16 in total

Review 1.  Commentary. Lysosomotropic agents.

Authors:  C de Duve; T de Barsy; B Poole; A Trouet; P Tulkens; F Van Hoof
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

2.  Cyclic AMP-dependent protein kinase from bovine heart muscle.

Authors:  C S Rubin; J Erlichman; O M Rosen
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

3.  Regulation of fructose-1,6-bisphosphatase in yeast by phosphorylation/dephosphorylation.

Authors:  D Müller; H Holzer
Journal:  Biochem Biophys Res Commun       Date:  1981-12-15       Impact factor: 3.575

4.  Cyclic AMP-dependent phosphorylation of fructose-1,6-bisphosphatase in yeast.

Authors:  C Purwin; F Leidig; H Holzer
Journal:  Biochem Biophys Res Commun       Date:  1982-08-31       Impact factor: 3.575

5.  Affinity labeling of the catalytic subunit of cyclic AMP-dependent protein kinase by N alpha-tosyl-L-lysine chloromethyl ketone.

Authors:  A Kupfer; V Gani; J S Jiménez; S Shaltiel
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

6.  Characterization of fructose 1,6-bisphosphatase from bakers' yeast.

Authors:  T Noda; H Hoffschulte; H Holzer
Journal:  J Biol Chem       Date:  1984-06-10       Impact factor: 5.157

7.  Inactivation of yeast fructose-1,6-bisphosphatase. In vivo phosphorylation of the enzyme.

Authors:  M J Mazón; J M Gancedo; C Gancedo
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

8.  Phosphorylation and inactivation of yeast fructose-1,6-bisphosphatase by cyclic AMP-dependent protein kinase from yeast.

Authors:  G Pohlig; H Holzer
Journal:  J Biol Chem       Date:  1985-11-05       Impact factor: 5.157

9.  Yeast cyclic AMP-dependent protein kinase.

Authors:  R Wingender-Drissen
Journal:  FEBS Lett       Date:  1983-10-31       Impact factor: 4.124

10.  Synthesis and processing of in vitro and in vivo precursors of the vacuolar yeast enzyme carboxypeptidase Y.

Authors:  M Müller; H Müller
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

View more
  3 in total

1.  Sensitivity of yeast glycolytic enzymes to chloroquine.

Authors:  A Manhart; H Kalisz; H Holzer
Journal:  Arch Microbiol       Date:  1988       Impact factor: 2.552

2.  Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro.

Authors:  M T Labro; C Babin-Chevaye
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

Review 3.  Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.

Authors:  Seidu A Richard; Sylvanus Kampo; Maite Esquijarosa Hechavarria; Marian Sackey; Alexis D B Buunaaim; Eugene Dogkotenge Kuugbee; Thomas Winsum Anabah
Journal:  J Immunol Res       Date:  2020-09-25       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.